FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Leuchter

Research Profile

Procedures

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Activities & Behaviors

Computer-Assisted Signal Processing

Physiology

Theta Rhythm

Co-author Network

Publications

TOP 3
Aimee M Hunter; Alexander S Korb; Ian A Cook; Andrew F Leuchter
Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?
Andrew F Leuchter; Ian A Cook; Yi Jin; Bill Phillips
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder.
Ian A Cook; William S Gilmer; Scott Greenwald; Robert H Howland; Aimee M Hunter; Dan V Iosifescu; Rakesh Jain; Madhukar H Trivedi; Sidney Zisook; Karl Burgoyne; Andrew F Leuchter
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Leuchter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Aimee M Hunter; Alexander S Korb; Ian A Cook; Andrew F Leuchter
Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?
The Journal of neuropsychiatry and clinical neurosciences 2013;25(2):126-33.
2013: Andrew F Leuchter; Ian A Cook; Yi Jin; Bill Phillips
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder.
Frontiers in human neuroscience 2013;7():37.
2013: Ian A Cook; William S Gilmer; Scott Greenwald; Robert H Howland; Aimee M Hunter; Dan V Iosifescu; Rakesh Jain; Madhukar H Trivedi; Sidney Zisook; Karl Burgoyne; Andrew F Leuchter
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
The Journal of clinical psychiatry 2013;74(1):51-6.
2012: Andrew F Leuchter; Ian A Cook; Aimee M Hunter
Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'.
Journal of psychopharmacology (Oxford, England) 2012;26(8):1162-3; author reply 1164.
2012: Andrew F Leuchter; Aimee M Hunter; Chaochao Cai; Ian A Cook; Steve Horvath
Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression.
PloS one 2012;7(2):e32508.
2011: Alexander S Korb; Aimee M Hunter; Ian A Cook; Andrew F Leuchter
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.
Psychiatry research 2011;192(3):188-94.
2011: M Rabinoff; C M R Kitchen; Ian A Cook; Andrew F Leuchter
Evaluation of quantitative EEG by classification and regression trees to characterize responders to antidepressant and placebo treatment.
The open medical informatics journal 2011;5():1-8.
2010: Aimee M Hunter; Ian A Cook; Andrew F Leuchter
Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression.
Journal of clinical psychopharmacology 2010;30(6):748-51.
2010: Andrew F Leuchter; Ian A Cook; Steven Hamilton; Owen Phillips; Arthur W Toga; Aimee M Hunter; Kym Faull; Julian Whitelegge; Anne M Andrews; Joseph Loo; Baldwin M Way; Stanley F Nelson; Steven Horvath; Barry D Lebowitz
Biomarkers to predict antidepressant response.
Current psychiatry reports 2010;12(6):553-62.
2010: Aimee M Hunter; Andrew F Leuchter; Ian A Cook; Michelle Abrams
Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.
Acta psychiatrica Scandinavica 2010;122(6):461-9.
2010: Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Benji Kurian; Sidney Zisook; Susan G Kornstein; Edward S Friedman; Sachiko Miyahara; Andrew F Leuchter; Maurizio Fava; A John Rush
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.
Journal of clinical psychopharmacology 2010;30(3):259-66.
2010: Andrew F Leuchter; M M Husain; Ian A Cook; Madhukar H Trivedi; Stephen R Wisniewski; W S Gilmer; J F Luther; M Fava; A John Rush
Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
Psychological medicine 2010;40(2):239-51.
2010: Aimee Hunter; Yvette Bordelon; Ian Cook; Andrew F Leuchter
QEEG Measures in Huntington's Disease: A Pilot Study.
PLoS currents 2010;2():RRN1192.
2010: Haleh Farahbod; Ian A Cook; Alexander S Korb; Aimee M Hunter; Andrew F Leuchter
Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2010;41(1):19-23.
2010: Aimee M Hunter; Bengt Muthén; Ian A Cook; Andrew F Leuchter
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.
Journal of psychiatric research 2010;44(2):90-8.
2009: Ian A Cook; Aimee M Hunter; Michelle Abrams; Barbara Siegman; Andrew F Leuchter
Midline and right frontal brain function as a physiologic biomarker of remission in major depression.
Psychiatry research 2009;174(2):152-7.
2009: Andrew F Leuchter; Ian A Cook; Lauren B Marangell; William S Gilmer; Karl Burgoyne; Robert H Howland; Madhukar H Trivedi; Sidney Zisook; Rakesh Jain; James T McCracken; Maurizio Fava; Dan Iosifescu; Scott Greenwald
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
Psychiatry research 2009;169(2):124-31.
2009: Andrew F Leuchter; Ian A Cook; William S Gilmer; Lauren B Marangell; Karl Burgoyne; Robert H Howland; Madhukar H Trivedi; Sidney Zisook; Rakesh Jain; Maurizio Fava; Dan Iosifescu; Scott Greenwald
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Psychiatry research 2009;169(2):132-8.
2009: Andrew F Leuchter; James T McCracken; Aimee M Hunter; Ian A Cook; Jonathan E Alpert
Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder.
Journal of clinical psychopharmacology 2009;29(4):372-7.
2009: Alexander S Korb; Aimee M Hunter; Ian A Cook; Andrew F Leuchter
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2009;120(7):1313-9.
2009: Aimee M Hunter; Andrew F Leuchter; Ian A Cook; Michelle Abrams; Barbara E Siegman; Daniel E Furst; Amy S Chappell
Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.
Pain medicine (Malden, Mass.) 2009;10(4):730-8.
2009: Andrew F Leuchter; Ian A Cook; Aimee Hunter; Alex Korb
Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2009;40(2):78-83.
2009: Aimee M Hunter; S Ravikumar; Ian A Cook; Andrew F Leuchter
Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.
Acta psychiatrica Scandinavica 2009;119(4):266-73.
2009: Andrew F Leuchter; Ian A Cook; Aimee M Hunter; Alexander S Korb
A new paradigm for the prediction of antidepressant treatment response.
Dialogues in clinical neuroscience 2009;11(4):435-46.
2009: Ari D Kalechstein; Richard De la Garza; Thomas F Newton; Michael F Green; Ian A Cook; Andrew F Leuchter
Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.
The Journal of neuropsychiatry and clinical neurosciences 2009;21(3):254-8.
2008: Alexander S Korb; Ian A Cook; Aimee M Hunter; Andrew F Leuchter
Brain electrical source differences between depressed subjects and healthy controls.
Brain topography 2008;21(2):138-46.
2008: Andrew F Leuchter; Ian A Cook; David J DeBrota; Aimee M Hunter; William Z Potter; Caroline C McGrouther; Melinda L Morgan; Michelle Abrams; Barbara Siegman
Changes in brain function during administration of venlafaxine or placebo to normal subjects.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2008;39(4):175-81.
2008: Andrew F Leuchter; Ira M Lesser; Madhukar H Trivedi; A John Rush; David W Morris; Diane Warden; Maurizio Fava; Stephen R Wisniewski; James F Luther; Mercedes Perales; Bradley N Gaynes; Jonathan W Stewart
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
Journal of psychiatric practice 2008;14(5):271-80.
2007: David Shapiro; Ian A Cook; Dmitry M Davydov; Andrew F Leuchter; Cristina Ottaviani; Michelle Abrams
Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome.
Evidence-based complementary and alternative medicine : eCAM 2007;4(4):493-502.
2007: Andrew F Leuchter; Gerald S Levey
Need to strike balance with industry-academia rules.
Nature 2007;449(7163):658.
2007: Ira M Lesser; Andrew F Leuchter; Madhukar H Trivedi; Lori Davis; Stephen R Wisniewski; Balasubramani G.K.; Maurizio Fava; A John Rush
Insured and non-insured depressed outpatients: how do they compare?
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(2):73-82.
2007: Ian A Cook; Susan Y Bookheimer; Laura Mickes; Andrew F Leuchter; Anand Kumar
Aging and brain activation with working memory tasks: an fMRI study of connectivity.
International journal of geriatric psychiatry 2007;22(4):332-42.
2007: Aimee M Hunter; Ian A Cook; Andrew F Leuchter
The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.
The Psychiatric clinics of North America 2007;30(1):105-24.
2007: Melinda L Morgan; Ian A Cook; Andrea J Rapkin; Andrew F Leuchter
Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
Maturitas 2007;56(1):54-60.
2007: Cynthia A Claassen; Madhukar H Trivedi; john rush; Mustafa M Husain; Sidney Zisook; Elizabeth Young; Andrew F Leuchter; Stephen R Wisniewski; Balasubramani G.K.; Jonathan Alpert
Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.
Journal of affective disorders 2007;97(1-3):77-84.
2006: Aimee M Hunter; Andrew F Leuchter; Melinda L Morgan; Ian A Cook
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
The American journal of psychiatry 2006;163(8):1426-32.
2006: Tally Moses; Andrew F Leuchter; Ian Cook; Michelle Abrams
Does the clinical course of depression determine improvement in symptoms and quality of life?
The Journal of nervous and mental disease 2006;194(4):241-8.
2006: Sandy Venneman; Andrew F Leuchter; George Bartzokis; Mace Beckson; Sara L Simon; Melodie Schaefer; Richard Rawson; Thomas F Newton; Ian A Cook; Sebastian Uijtdehaage; Walter Ling
Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition.
The Journal of neuropsychiatry and clinical neurosciences 2006;18(2):208-16.
2005: Heather V Krell; Andrew F Leuchter; Ian A Cook; Michelle Abrams
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain.
Psychosomatics 2005;46(5):379-84.
2005: Ian A Cook; Andrew F Leuchter; Melinda L Morgan; William F Stubbeman; Barbara Siegman; Michelle Abrams
Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.
Journal of psychiatric research 2005;39(5):461-6.
2005: Ira M Lesser; Andrew F Leuchter; Madhukar H Trivedi; Lori Davis; Stephen R Wisniewski; Balasubramani G.K.; Timothy Petersen; Diane Stegman; A John Rush
Characteristics of insured and noninsured outpatients with depression in STAR(*)D.
Psychiatric services (Washington, D.C.) 2005;56(8):995-1004.
2005: Melinda L Morgan; Ian A Cook; Andrea J Rapkin; Andrew F Leuchter
Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study.
The Journal of clinical psychiatry 2005;66(6):774-80.
2005: Aimee M Hunter; Andrew F Leuchter; Melinda L Morgan; Ian A Cook; Michelle Abrams; Barbara Siegman; David J DeBrota; William Z Potter
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(4):792-9.
2005: Melinda L Morgan; Elise Witte; Ian A Cook; Andrew F Leuchter; Michelle Abrams; Barbara Siegman
Influence of age, gender, health status, and depression on quantitative EEG.
Neuropsychobiology 2005;52(2):71-6.
2004: Andrew F Leuchter; Melinda Morgan; Ian A Cook; Jennifer J Dunkin; Michelle Abrams; Elise Witte
Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.
Psychopharmacology 2004;177(1-2):15-22.
2004: Heather V Krell; Andrew F Leuchter; Melinda Morgan; Ian A Cook; Michelle Abrams
Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.
The Journal of clinical psychiatry 2004;65(9):1174-9.
2004: William F Stubbeman; Andrew F Leuchter; Ian A Cook; Brett D Shurman; Melinda Morgan; Ibrahim Gunay; Sergio Gonzalez
Pretreatment neurophysiologic function and ECT response in depression.
The journal of ECT 2004;20(3):142-4.
2004: Ariane Marie-Mitchell; Andrew F Leuchter; Chih-Ping Chou; W James Gauderman; Stanley P Azen
Predictors of improved mood over time in clinical trials for major depression.
Psychiatry research 2004;127(1-2):73-84.
2004: Ian A Cook; Andrew F Leuchter; Melinda L Morgan; Jennifer J Dunkin; Elise Witte; Steven David; Laura Mickes; Ruth O'Hara; Sara Simon; Robert Lufkin; Michelle Abrams; Susan Rosenberg
Longitudinal progression of subclinical structural brain disease in normal aging.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2004;12(2):190-200.
2004: Thomas F Newton; Ari D Kalechstein; David J Hardy; Ian A Cook; Liam Nestor; Walter Ling; Andrew F Leuchter
Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2004;115(1):194-8.
2003: Thomas F Newton; Ian A Cook; Ari D Kalechstein; Sonia Duran; Franz Monroy; Walter Ling; Andrew F Leuchter
Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2003;114(3):410-5.
2002: Ian A Cook; Andrew F Leuchter; Melinda L Morgan; Elise Witte Conlee; Steven David; Robert Lufkin; Ashkan Babaie; Jennifer J Dunkin; Ruth O'Hara; Sara Simon; Amy Lightner; Susan Thomas; David Broumandi; Neeraj Badjatia; Laura Mickes; Rajal K Mody; Sanjaya Arora; Zimu Zheng; Michelle Abrams; Susan Rosenberg-Thompson
Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.
Archives of neurology 2002;59(10):1612-20.
2002: Ian A Cook; Melinda L Morgan; Jennifer J Dunkin; Steven David; Elise Witte; Robert Lufkin; Michelle Abrams; Susan Rosenberg; Andrew F Leuchter
Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.
International journal of geriatric psychiatry 2002;17(7):610-8.
2002: Ian A Cook; Andrew F Leuchter; Melinda Morgan; Elise Witte; William F Stubbeman; Michelle Abrams; Susan Rosenberg; Sebastian Uijtdehaage
Early changes in prefrontal activity characterize clinical responders to antidepressants.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(1):120-31.
2002: Andrew F Leuchter; Ian A Cook; Elise Witte; Melinda Morgan; Michelle Abrams
Changes in brain function of depressed subjects during treatment with placebo.
The American journal of psychiatry 2002;159(1):122-9.
2001: Ian A Cook; Andrew F Leuchter
Prefrontal changes and treatment response prediction in depression.
Seminars in clinical neuropsychiatry 2001;6(2):113-20.
2000: Jennifer J Dunkin; Andrew F Leuchter; Ian A Cook; J E Kasl-Godley; Michelle Abrams; Susan Rosenberg-Thompson
Executive dysfunction predicts nonresponse to fluoxetine in major depression.
Journal of affective disorders 2000;60(1):13-23.
2000: T Edwards-Lee; I Cook; Lynn Fairbanks; Andrew F Leuchter; Jeffrey L Cummings
Quantitative electroencephalographic correlates of psychosis in Alzheimer disease.
Neuropsychiatry, neuropsychology, and behavioral neurology 2000;13(3):163-70.
2000: Daniel P Holschneider; Andrew F Leuchter
Attenuation of brain high frequency electrocortical response after thiopental in early stages of Alzheimer's dementia.
Psychopharmacology 2000;149(1):6-11.
1999: Daniel P Holschneider; Jerene J Waite; Andrew F Leuchter; NY Walton; Oscar Scremin
Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1999;126(2):270-80.
1999: Andrew F Leuchter; Sebastian Uijtdehaage; Ian A Cook; Ruth O'Hara; Mark A Mandelkern
Relationship between brain electrical activity and cortical perfusion in normal subjects.
Psychiatry research 1999;90(2):125-40.
1999: Ian A Cook; Andrew F Leuchter; Elise Witte; Michelle Abrams; Sebastian Uijtdehaage; William F Stubbeman; Susan Rosenberg-Thompson; C Anderson-Hanley; Jennifer J Dunkin
Neurophysiologic predictors of treatment response to fluoxetine in major depression.
Psychiatry research 1999;85(3):263-73.
1999: Alexander Bystritsky; Andrew F Leuchter; Tanya Vapnik
EEG abnormalities in nonmedicated panic disorder.
The Journal of nervous and mental disease 1999;187(2):113-4.
1999: Daniel P Holschneider; Andrew F Leuchter
Clinical neurophysiology using electroencephalography in geriatric psychiatry: neurobiologic implications and clinical utility.
Journal of geriatric psychiatry and neurology 1999;12(3):150-64.
1998: Ian A Cook; Ruth O'Hara; Sebastian Uijtdehaage; Mark A Mandelkern; Andrew F Leuchter
Assessing the accuracy of topographic EEG mapping for determining local brain function.
Electroencephalography and clinical neurophysiology 1998;107(6):408-14.
1998: Ian A Cook; Andrew F Leuchter; Sebastian Uijtdehaage; S Osato; D H Holschneider; Michelle Abrams; Susan Rosenberg-Thompson
Altered cerebral energy utilization in late life depression.
Journal of affective disorders 1998;49(2):89-99.
1998: Daniel P Holschneider; Andrew F Leuchter; Oscar Scremin; David Treiman; NY Walton
Effects of cholinergic deafferentation and NGF on brain electrical coherence.
Brain research bulletin 1998;45(5):531-41.
1997: Daniel P Holschneider; Andrew F Leuchter; NY Walton; Oscar Scremin; David Treiman
Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions.
Brain research 1997;765(2):228-37.
1997: Daniel P Holschneider; Andrew F Leuchter; Sebastian Uijtdehaage; Michelle Abrams; Susan Rosenberg-Thompson
Loss of high-frequency brain electrical response to thiopental administration in Alzheimer's-type dementia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(4):269-75.
1997: T F Newton; Andrew F Leuchter; Wilfred G van Gorp; Charles H Hinkin; Mark A Mandelkern; H Weiner
EEG power correlates with subcortical metabolic activity in AIDS.
The Journal of neuropsychiatry and clinical neurosciences 1997;9(4):574-8.
1997: Andrew F Leuchter; Ian A Cook; Sebastian Uijtdehaage; Jennifer J Dunkin; Robert Lufkin; C Anderson-Hanley; Michelle Abrams; Susan Rosenberg-Thompson; Ruth O'Hara; Sara L Simon; S Osato; A Babaie
Brain structure and function and the outcomes of treatment for depression.
The Journal of clinical psychiatry 1997;58 Suppl 16():22-31.
1996: Ian A Cook; Andrew F Leuchter
Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG.
Behavioural brain research 1996;78(1):15-23.
1996: G G Yener; Andrew F Leuchter; D Jenden; S L Read; Jeffrey L Cummings; Bruce L Miller
Quantitative EEG in frontotemporal dementia.
Clinical EEG (electroencephalography) 1996;27(2):61-8.
1995: Daniel P Holschneider; Andrew F Leuchter
Beta activity in aging and dementia.
Brain topography 1995;8(2):169-80.
1995: Jennifer J Dunkin; S Osato; Andrew F Leuchter
Relationships between EEG coherence and neuropsychological tests in dementia.
Clinical EEG (electroencephalography) 1995;26(1):47-59.
1994: Andrew F Leuchter; Jennifer J Dunkin; R B Lufkin; Y Anzai; Ian A Cook; T F Newton
Effect of white matter disease on functional connections in the aging brain.
Journal of neurology, neurosurgery, and psychiatry 1994;57(11):1347-54.
1994: T F Newton; Andrew F Leuchter; D O Walter; Wilfred G van Gorp; H Morgenstern; Eric N Miller; K Lieb; Barbara Visscher; Paul Satz; H Weiner
Electroencephalographic coherence in acquired immune deficiency syndrome.
Psychiatry research 1994;54(1):1-11.
1994: Andrew F Leuchter; Ian A Cook; I Mena; Jennifer J Dunkin; Jeffrey L Cummings; T F Newton; Octave Migneco; R B Lufkin; D O Walter; P A Lachenbruch
Assessment of cerebral perfusion using quantitative EEG cordance.
Psychiatry research 1994;55(3):141-52.
1994: Andrew F Leuchter; Ian A Cook; R B Lufkin; Jennifer J Dunkin; T F Newton; Jeffrey L Cummings; J K Mackey; D O Walter
Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography.
NeuroImage 1994;1(3):208-19.
1994: Jennifer J Dunkin; Andrew F Leuchter; T F Newton; Ian A Cook
Reduced EEG coherence in dementia: state or trait marker?
Biological psychiatry 1994;35(11):870-9.
1994: T F Newton; Andrew F Leuchter; Eric N Miller; H Weiner
Quantitative EEG in patients with AIDS and asymptomatic HIV infection.
Clinical EEG (electroencephalography) 1994;25(1):18-25.
1993: Andrew F Leuchter; Ian A Cook; T F Newton; Jennifer J Dunkin; D O Walter; Susan Rosenberg-Thompson; P A Lachenbruch; H Weiner
Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures.
Electroencephalography and clinical neurophysiology 1993;87(6):385-93.
1993: S A Jacobson; Andrew F Leuchter; D O Walter; H Weiner
Serial quantitative EEG among elderly subjects with delirium.
Biological psychiatry 1993;34(3):135-40.
1993: Andrew F Leuchter; K A Daly; Susan Rosenberg-Thompson; Michelle Abrams
Prevalence and significance of electroencephalographic abnormalities in patients with suspected organic mental syndromes.
Journal of the American Geriatrics Society 1993;41(6):605-11.
1993: S A Jacobson; Andrew F Leuchter; D O Walter
Conventional and quantitative EEG in the diagnosis of delirium among the elderly.
Journal of neurology, neurosurgery, and psychiatry 1993;56(2):153-8.
1993: Gary W Small; Andrew F Leuchter; Mark A Mandelkern; Asenath La Rue; A Okonek; R B Lufkin; L F Jarvik; S S Matsuyama; W Bondareff
Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type.
Archives of neurology 1993;50(2):209-19.
1993: T F Newton; Andrew F Leuchter; D O Walter; W C Van Gorp; C E Stern; Mark A Mandelkern; H Weiner
EEG coherence in men with AIDS: association with subcortical metabolic activity.
The Journal of neuropsychiatry and clinical neurosciences 1993;5(3):316-21.
1992: Andrew F Leuchter; T F Newton; Ian A Cook; D O Walter; Susan Rosenberg-Thompson; P A Lachenbruch
Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia.
Brain : a journal of neurology 1992;115 ( Pt 5)():1543-61.
1992: Martin P Szuba; Andrew F Leuchter
Falling backward in two elderly patients taking bupropion.
The Journal of clinical psychiatry 1992;53(5):157-9.
1991: Andrew F Leuchter; S L Read; J Shapira; D O Walter; C Smith
Stable bimodal response to cholinomimetic drugs in Alzheimer's disease. Brain mapping correlates.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1991;4(3):165-73.
1991: Andrew F Leuchter; S A Jacobson
Quantitative measurement of brain electrical activity in delirium.
International psychogeriatrics / IPA 1991;3(2):231-47.
1989: Andrew F Leuchter; D O Walter
Diagnosis and assessment of dementia using functional brain imaging.
International psychogeriatrics / IPA 1989;1(1):63-72.
1987: Andrew F Leuchter; J E Spar; D O Walter; H Weiner
Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study.
Archives of general psychiatry 1987;44(11):993-8.
1985: Andrew F Leuchter; J E Spar
The late-onset psychoses. Clinical and diagnostic features.
The Journal of nervous and mental disease 1985;173(8):488-94.